Barclay Alec
Chief Operations Officer at T2 Biosystems, Inc.
- Sold, on record
- $55k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 17, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- T2 Biosystems, Inc.Chief Operations Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale T2 Biosystems, Inc.Plan not statedSep 11, 2019 2019
Sold 4,210 shares at $2.92 ($12k)
Barclay Alec, SVP, Operations
Sold 9.1% of holdings ($135k position)42,102 shares leftFirst sale on recordFiling
- 2 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 24, 2020 +166 days
Sold 5,808 shares at $0.82 ($5k)
Barclay Alec, SVP, Operations
Sold 11.1% of holdings ($43k position)46,294 shares leftFiling
- 3 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 23, 2021 +365 days
Sold 7,280 shares at $2.06 ($15k)
Barclay Alec, Chief Operations Officer
Sold 10% of holdings ($149k position)65,247 shares leftFiling
- 4 Form 4 sale T2 Biosystems, Inc.Plan not statedMar 17, 2021 +22 days
Sold 12,494 shares at $1.86 ($23k)
Barclay Alec, Chief Operations Officer
Sold 14.4% of holdings ($162k position)74,420 shares left2.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2021 | Mar 18, 2021 | T2 Biosystems, Inc. | Chief Operations Officer | Form 4 sale | 12,494 | $23k | 14.4% | Plan not stated | SEC |
| Feb 23, 2021 | Feb 23, 2021 | T2 Biosystems, Inc. | Chief Operations Officer | Form 4 sale | 7,280 | $15k | 10.0% | Plan not stated | SEC |
| Feb 24, 2020 | Feb 25, 2020 | T2 Biosystems, Inc. | SVP, Operations | Form 4 sale | 5,808 | $5k | 11.1% | Plan not stated | SEC |
| Sep 11, 2019 | Sep 13, 2019 | T2 Biosystems, Inc. | SVP, Operations | Form 4 sale | 4,210 | $12k | 9.1% | Plan not stated | SEC |